{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T01:54:08Z","timestamp":1785462848813,"version":"3.56.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T00:00:00Z","timestamp":1704758400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T00:00:00Z","timestamp":1704758400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Introduction<\/jats:title>\n                <jats:p>Perchlorates are ionic inhibitors antagonizing iodine transport into thyrocytes, hampering thyroid hormone synthesis. Nevertheless, perchlorates are not considered as first-line treatment in hyperthyroidism and thyrotoxicosis as compared to other pharmacological and non-pharmacological interventions.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Aim<\/jats:title>\n                <jats:p>Reassessing the therapeutic role of perchlorates in hyperthyroidism and thyrotoxicosis throughout a systematic review of the Literature.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Guidelines were searched and examined to summarize current recommendations on the use of perchlorates in the management of hyperthyroidism. Randomized and non-randomized clinical trials were also searched and reviewed to summarize the efficacy\/effectiveness and safety of perchlorates in hyperthyroidisms and thyrotoxicosis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The management of specific forms of hyperthyroidism was considered, including Graves\u2019 disease (GD) in non-pregnant adults, hyperthyroidisms in pregnancy, iodine media contrast-induced hyperthyroidism, amiodarone-induced hyperthyroidisms, and thyroid storm. Most of the reported studies had remarkable limitations in terms of study design (non-controlled trials, lack of blinding), low number of participants, and the lack of clinically relevant endpoints, such as cardiovascular events, cardiovascular mortality, and teratogenicity. Overall, perchlorates could be considered a second-line treatment after thionamides, radioiodine, and total thyroidectomy in both GD and hyperthyroidisms in pregnancy. The therapeutic potential of perchlorates alone or in combination with other agents could be considered a second-line treatment of iodine-related hyperthyroidisms and thyroid storm.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Despite the low level of evidence, perchlorates could be considered in such specific forms of thyroid disorders, including iodine-induced hyperthyroidism and thyroid storm.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s12020-023-03679-y","type":"journal-article","created":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T19:02:31Z","timestamp":1704826951000},"page":"1-10","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Perchlorates in the treatment of hyperthyroidism and thyrotoxicosis: a comprehensive review"],"prefix":"10.1007","volume":"85","author":[{"given":"Giuseppe","family":"Lisco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Accardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cinzia","family":"Pupilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasqualino","family":"Malandrino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"De Geronimo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Triggiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,9]]},"reference":[{"issue":"6","key":"3679_CR1","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.3390\/nu12061669","volume":"12","author":"G Lisco","year":"2020","unstructured":"G. Lisco, A. De Tullio, V.A. Giagulli, G. De Pergola, V. Triggiani, Interference on Iodine Uptake and Human Thyroid Function by Perchlorate-Contaminated Water and Food. Nutrients 12(6), 1669 (2020). https:\/\/doi.org\/10.3390\/nu12061669","journal-title":"Nutrients"},{"issue":"1","key":"3679_CR2","first-page":"89","volume":"50","author":"J Wolff","year":"1998","unstructured":"J. Wolff, Perchlorate and the thyroid gland. Pharm. Rev. 50(1), 89\u2013105 (1998)","journal-title":"Pharm. Rev."},{"issue":"4","key":"3679_CR3","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1097\/00007691-200108000-00002","volume":"23","author":"OP Soldin","year":"2001","unstructured":"O.P. Soldin, L.E. Braverman, S.H. Lamm, Perchlorate clinical pharmacology and human health: a review. Ther. Drug Monit. 23(4), 316\u2013331 (2001). https:\/\/doi.org\/10.1097\/00007691-200108000-00002","journal-title":"Ther. Drug Monit."},{"issue":"1","key":"3679_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s12940-021-00818-8","volume":"21","author":"H Wang","year":"2022","unstructured":"H. Wang, Y. Jiang, J. Song, H. Liang, Y. Liu, J. Huang, P. Yin, D. Wu, H. Zhang, X. Liu, D. Zhou, W. Wei, L. Lei, J. Peng, J. Zhang, The risk of perchlorate and iodine on the incidence of thyroid tumors and nodular goiter: a case-control study in southeastern China. Environ. Health 21(1), 4 (2022). https:\/\/doi.org\/10.1186\/s12940-021-00818-8","journal-title":"Environ. Health"},{"issue":"10","key":"3679_CR5","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1089\/thy.2016.0229","volume":"26","author":"DS Ross","year":"2016","unstructured":"D.S. Ross, H.B. Burch, D.S. Cooper, M.C. Greenlee, P. Laurberg, A.L. Maia, S.A. Rivkees, M. Samuels, J.A. Sosa, M.N. Stan, M.A. Walter, 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis. Thyroid 26(10), 1343\u20131421 (2016). https:\/\/doi.org\/10.1089\/thy.2016.0229","journal-title":"Thyroid"},{"issue":"3","key":"3679_CR6","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1210\/endo-43-3-174","volume":"43","author":"J Wolff","year":"1948","unstructured":"J. Wolff, I.L. Chaikoff, The inhibitory action of excessive iodide upon the synthesis of diiodotyrosine and of thyroxine in the thyroid gland of the normal rat. Endocrinology 43(3), 174\u2013179 (1948). https:\/\/doi.org\/10.1210\/endo-43-3-174","journal-title":"Endocrinology"},{"issue":"5","key":"3679_CR7","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1089\/105072501300176462","volume":"11","author":"K Markou","year":"2001","unstructured":"K. Markou, N. Georgopoulos, V. Kyriazopoulou, A.G. Vagenakis, Iodine-Induced hypothyroidism. Thyroid 11(5), 501\u2013510 (2001). https:\/\/doi.org\/10.1089\/105072501300176462","journal-title":"Thyroid"},{"issue":"8","key":"3679_CR8","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1089\/thy.2016.0051","volume":"26","author":"E Kornelius","year":"2016","unstructured":"E. Kornelius, J.Y. Chiou, Y.S. Yang, S.C. Lo, C.H. Peng, Y.R. Lai, C.N. Huang, Iodinated Contrast Media-Induced Thyroid Dysfunction in Euthyroid Nodular Goiter Patients. Thyroid 26(8), 1030\u20131038 (2016). https:\/\/doi.org\/10.1089\/thy.2016.0051","journal-title":"Thyroid"},{"issue":"4","key":"3679_CR9","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1111\/j.1365-2265.2007.02920.x","volume":"67","author":"F Bogazzi","year":"2007","unstructured":"F. Bogazzi, L. Bartalena, E. Dell\u2019Unto, L. Tomisti, G. Rossi, P. Pepe, M.L. Tanda, L. Grasso, E. Macchia, F. Aghini-Lombardi, A. Pinchera, E. Martino, Proportion of type 1 and type 2 amiodarone-induced thyrotoxicosis has changed over a 27-year period in Italy. Clin. Endocrinol. 67(4), 533\u2013537 (2007). https:\/\/doi.org\/10.1111\/j.1365-2265.2007.02920.x","journal-title":"Clin. Endocrinol."},{"issue":"4","key":"3679_CR10","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1111\/cen.12818","volume":"84","author":"C Jarvis","year":"2016","unstructured":"C. Jarvis, K. Simcox, J.A. Tamatea, K. McAnulty, G.Y. Meyer-Rochow, J.V. Conaglen, M.S. Elston, A low incidence of iodine-induced hyperthyroidism following administration of iodinated contrast in an iodine-deficient region. Clin. Endocrinol. 84(4), 558\u2013563 (2016). https:\/\/doi.org\/10.1111\/cen.12818","journal-title":"Clin. Endocrinol."},{"issue":"7","key":"3679_CR11","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1089\/thy.2020.0459","volume":"31","author":"S Bervini","year":"2021","unstructured":"S. Bervini, S. Trelle, P. Kopp, C. Stettler, R. Trepp, Prevalence of Iodine-Induced Hyperthyroidism After Administration of Iodinated Contrast During Radiographic Procedures: A Systematic Review and Meta-Analysis of the Literature. Thyroid 31(7), 1020\u20131029 (2021). https:\/\/doi.org\/10.1089\/thy.2020.0459. 14","journal-title":"Thyroid"},{"issue":"9","key":"3679_CR12","doi-asserted-by":"publisher","first-page":"3372","DOI":"10.1210\/JC.2015-2329","volume":"100","author":"E Kornelius","year":"2015","unstructured":"E. Kornelius, J.Y. Chiou, Y.S. Yang, C.H. Peng, Y.R. Lai, C.N. Huang, Iodinated Contrast Media Increased the Risk of Thyroid Dysfunction: A 6-Year Retrospective Cohort Study. J. Clin. Endocrinol. Metab. 100(9), 3372\u20133379 (2015). https:\/\/doi.org\/10.1210\/JC.2015-2329","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"3679_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5603\/EP.a2023.0014","volume":"74","author":"T Bednarczuk","year":"2023","unstructured":"T. Bednarczuk, D. Kajdaniuk, B. Marek, M. Bolanowski, M. Dedecjus, A. Gilis-Januszewska, A. Hubalewska-Dydejczyk, B. Jarz\u0105b, R. Junik, G. Kami\u0144ski, B. Kos-Kud\u0142a, A. Kowalska, A. Lewi\u0144ski, B. Matyjaszek-Matuszek, M. Rucha\u0142a, L. Siemi\u0144ska, K. Sworczak, A. Syrenicz, W. Zgliczy\u0144ski, Basics of prevention and management of iodine-based contrast media-induced thyroid dysfunction - position paper by the Polish Society of Endocrinology. Endokrynol. Pol. 74(1), 1\u20134 (2023). https:\/\/doi.org\/10.5603\/EP.a2023.0014","journal-title":"Endokrynol. Pol."},{"issue":"4","key":"3679_CR14","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1159\/000490384","volume":"7","author":"GJ Kahaly","year":"2018","unstructured":"G.J. Kahaly, L. Bartalena, L. Heged\u00fcs, L. Leenhardt, K. Poppe, S.H. Pearce, 2018 European Thyroid Association Guideline for the Management of Graves\u2019 Hyperthyroidism. Eur. Thyroid J. 7(4), 167\u2013186 (2018). https:\/\/doi.org\/10.1159\/000490384","journal-title":"Eur. Thyroid J."},{"issue":"1","key":"3679_CR15","doi-asserted-by":"publisher","first-page":"e210073","DOI":"10.1530\/ETJ-21-0073","volume":"11","author":"CF Mooij","year":"2022","unstructured":"C.F. Mooij, T.D. Cheetham, F.A. Verburg, A. Eckstein, S.H. Pearce, J. L\u00e9ger, A.S.P. van Trotsenburg, 2022 European Thyroid Association Guideline for the management of pediatric Graves\u2019 disease. Eur. Thyroid J. 11(1), e210073 (2022). https:\/\/doi.org\/10.1530\/ETJ-21-0073","journal-title":"Eur. Thyroid J."},{"issue":"3","key":"3679_CR16","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1089\/thy.2016.0457","volume":"27","author":"EK Alexander","year":"2017","unstructured":"E.K. Alexander, E.N. Pearce, G.A. Brent, R.S. Brown, H. Chen, C. Dosiou, W.A. Grobman, P. Laurberg, J.H. Lazarus, S.J. Mandel, R.P. Peeters, S. Sullivan, 2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum. Thyroid 27(3), 315\u2013389 (2017). https:\/\/doi.org\/10.1089\/thy.2016.0457. Erratum in: Thyroid. 2017, 27(9), 1212","journal-title":"Thyroid"},{"issue":"6","key":"3679_CR17","doi-asserted-by":"publisher","first-page":"714","DOI":"10.3348\/kjr.2011.12.6.714","volume":"12","author":"SC Jung","year":"2011","unstructured":"S.C. Jung, S.H. Kim, J.Y. Cho, A comparison of the use of contrast media with different iodine concentrations for multidetector CT of the kidney. Korean J. Radio. 12(6), 714\u2013721 (2011). https:\/\/doi.org\/10.3348\/kjr.2011.12.6.714. Nov-DecEpub 2011 Sep 27. PMID: 22043154; PMCID: PMC3194776.","journal-title":"Korean J. Radio."},{"issue":"2","key":"3679_CR18","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1159\/000486957","volume":"7","author":"L Bartalena","year":"2018","unstructured":"L. Bartalena, F. Bogazzi, L. Chiovato, A. Hubalewska-Dydejczyk, T.P. Links, M. Vanderpump, 2018 European Thyroid Association (ETA) Guidelines for the Management of Amiodarone-Associated Thyroid Dysfunction. Eur. Thyroid J. 7(2), 55\u201366 (2018). https:\/\/doi.org\/10.1159\/000486957","journal-title":"Eur. Thyroid J."},{"issue":"4","key":"3679_CR19","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1159\/000517175","volume":"10","author":"T Bednarczuk","year":"2021","unstructured":"T. Bednarczuk, T.H. Brix, W. Schima, G. Zettinig, G.J. Kahaly, 2021 European Thyroid Association Guidelines for the Management of Iodine-Based Contrast Media-Induced Thyroid Dysfunction. Eur. Thyroid J. 10(4), 269\u2013284 (2021). https:\/\/doi.org\/10.1159\/000517175","journal-title":"Eur. Thyroid J."},{"issue":"3","key":"3679_CR20","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1530\/eje.0.1340337","volume":"134","author":"Nolte","year":"1996","unstructured":"Nolte, R. Muller, H. Siggelkow, D. Emrich, M. Hufner, Prophylactic application of thyrostatic drugs during excessive iodine exposure in euthyroid patients with thyroid autonomy: a randomized study. Eur. J. Endocrinol. 134(3), 337\u2013341 (1996). https:\/\/doi.org\/10.1530\/eje.0.1340337","journal-title":"Eur. J. Endocrinol."},{"issue":"4","key":"3679_CR21","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1159\/000515126","volume":"10","author":"K Pelewicz","year":"2021","unstructured":"K. Pelewicz, R. Wolny, T. Bednarczuk, P. Mi\u015bkiewicz, Prevention of Iodinated Contrast Media-Induced Hyperthyroidism in Patients with Euthyroid Goiter. Eur. Thyroid J. 10(4), 306\u2013313 (2021). https:\/\/doi.org\/10.1159\/000515126","journal-title":"Eur. Thyroid J."},{"key":"3679_CR22","doi-asserted-by":"publisher","first-page":"1154251","DOI":"10.3389\/fendo.2023.1154251","volume":"14","author":"J Manso","year":"2023","unstructured":"J. Manso, I. Piva, S. Censi, C. Clausi, M. Bardi, B. Schiavon, I. Merante Boschin, F. Tona, C. Mian, Safety and efficacy of prophylactic treatment for hyperthyroidism induced by iodinated contrast media in a high-risk population. Front Endocrinol. 14, 1154251 (2023). https:\/\/doi.org\/10.3389\/fendo.2023.1154251","journal-title":"Front Endocrinol."},{"issue":"2","key":"3679_CR23","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1089\/105072503321319521","volume":"13","author":"MF Erdogan","year":"2003","unstructured":"M.F. Erdogan, S. G\u00fcle\u00e7, E. Tutar, N. Ba\u015fkal, G. Erdogan, A stepwise approach to the treatment of amiodarone-induced thyrotoxicosis. Thyroid 13(2), 205\u2013209 (2003). https:\/\/doi.org\/10.1089\/105072503321319521","journal-title":"Thyroid"},{"issue":"5","key":"3679_CR24","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1111\/j.1365-2265.2008.03268.x","volume":"69","author":"ML Tanda","year":"2008","unstructured":"M.L. Tanda, E. Piantanida, A. Lai, L. Liparulo, L. Sassi, F. Bogazzi, W.M. Wiersinga, L.E. Braverman, E. Martino, L. Bartalena, Diagnosis and management of amiodarone-induced thyrotoxicosis: similarities and differences between North American and European thyroidologists. Clin. Endocrinol. 69(5), 812\u2013818 (2008). https:\/\/doi.org\/10.1111\/j.1365-2265.2008.03268.x","journal-title":"Clin. Endocrinol."},{"issue":"2","key":"3679_CR25","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1210\/jc.2011-2390","volume":"97","author":"SA Eskes","year":"2012","unstructured":"S.A. Eskes, E. Endert, E. Fliers, R.B. Geskus, R.P. Dullaart, T.P. Links, W.M. Wiersinga, Treatment of amiodarone-induced thyrotoxicosis type 2: a randomized clinical trial. J. Clin. Endocrinol. Metab. 97(2), 499\u2013506 (2012). https:\/\/doi.org\/10.1210\/jc.2011-2390","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"3679_CR26","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1210\/jcem-58-1-62","volume":"58","author":"KW Wenzel","year":"1984","unstructured":"K.W. Wenzel, J.R. Lente, Similar effects of thionamide drugs and perchlorate on thyroid-stimulating immunoglobulins in Graves\u2019 disease: evidence against an immunosuppressive action of thionamide drugs. J. Clin. Endocrinol. Metab. 58(1), 62\u201369 (1984). https:\/\/doi.org\/10.1210\/jcem-58-1-62","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"3679_CR27","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/BF03348175","volume":"10","author":"MG Prentice","year":"1987","unstructured":"M.G. Prentice, G.A. Rayman, J. Alaghband-Zadeh, P.H. Wise, Thyroid stimulating immunoglobulin bioactivity during carbimazole therapy as measured by the cytochemical bioassay. J. Endocrinol. Invest 10(5), 483\u2013489 (1987). https:\/\/doi.org\/10.1007\/BF03348175","journal-title":"J. Endocrinol. Invest"},{"issue":"1","key":"3679_CR28","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/cen.12688","volume":"84","author":"L Bartalena","year":"2016","unstructured":"L. Bartalena, H.B. Burch, K.D. Burman, G.J. Kahaly, A 2013 European survey of clinical practice patterns in the management of Graves\u2019 disease. Clin. Endocrinol. (Oxf.) 84(1), 115\u2013120 (2016). https:\/\/doi.org\/10.1111\/cen.12688","journal-title":"Clin. Endocrinol. (Oxf.)"},{"issue":"6","key":"3679_CR29","first-page":"533","volume":"1","author":"JB Stanbury","year":"1952","unstructured":"J.B. Stanbury, J.B. Wyngaarden, Effect of perchlorate on the human thyroid gland. Metabolism 1(6), 533\u2013539 (1952)","journal-title":"Metabolism"},{"issue":"11","key":"3679_CR30","doi-asserted-by":"publisher","first-page":"3995","DOI":"10.1210\/jc.2013-4466","volume":"99","author":"K Okamura","year":"2014","unstructured":"K. Okamura, K. Sato, M. Fujikawa, S. Bandai, H. Ikenoue, T. Kitazono, Remission after potassium iodide therapy in patients with Graves\u2019 hyperthyroidism exhibiting thionamide-associated side effects. J. Clin. Endocrinol. Metab. 99(11), 3995\u20134002 (2014). https:\/\/doi.org\/10.1210\/jc.2013-4466","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"3679_CR31","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1210\/jc.2007-0229","volume":"92","author":"Y Erbil","year":"2007","unstructured":"Y. Erbil, Y. Ozluk, M. Giri\u015f, A. Salmaslioglu, H. Issever, U. Barbaros, Y. Kapran, S. Ozarma\u011fan, S. Tezelman, Effect of lugol solution on thyroid gland blood flow and microvessel density in the patients with Graves\u2019 disease. J. Clin. Endocrinol. Metab. 92(6), 2182\u20132189 (2007). https:\/\/doi.org\/10.1210\/jc.2007-0229","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"3679_CR32","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s00268-015-3298-8","volume":"40","author":"SM Huang","year":"2016","unstructured":"S.M. Huang, W.T. Liao, C.F. Lin, H.S. Sun, N.H. Chow, Effectiveness and Mechanism of Preoperative Lugol Solution for Reducing Thyroid Blood Flow in Patients with Euthyroid Graves\u2019 Disease. World J. Surg. 40(3), 505\u2013509 (2016). https:\/\/doi.org\/10.1007\/s00268-015-3298-8","journal-title":"World J. Surg."},{"issue":"7","key":"3679_CR33","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1176\/appi.ajp.2014.12111402","volume":"171","author":"O Diav-Citrin","year":"2014","unstructured":"O. Diav-Citrin, S. Shechtman, E. Tahover, V. Finkel-Pekarsky, J. Arnon, D. Kennedy, A. Erebara, A. Einarson, A. Ornoy, Pregnancy outcome following in utero exposure to lithium: a prospective, comparative, observational study. Am. J. Psychiatry 171(7), 785\u2013794 (2014). https:\/\/doi.org\/10.1176\/appi.ajp.2014.12111402","journal-title":"Am. J. Psychiatry"},{"issue":"4","key":"3679_CR34","doi-asserted-by":"publisher","first-page":"e238655","DOI":"10.1001\/jamanetworkopen.2023.8655","volume":"6","author":"SY Lee","year":"2023","unstructured":"S.Y. Lee, K.L. Modzelewski, A.C. Law, A.J. Walkey, E.N. Pearce, N.A. Bosch, Comparison of Propylthiouracil vs Methimazole for Thyroid Storm in Critically Ill Patients. JAMA Netw. Open 6(4), e238655 (2023). https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.8655","journal-title":"JAMA Netw. Open"},{"issue":"5","key":"3679_CR35","doi-asserted-by":"publisher","first-page":"e67","DOI":"10.1016\/j.jtcvs.2010.06.034","volume":"140","author":"LT Bish","year":"2010","unstructured":"L.T. Bish, J.E. Bavaria, J. Augoustides, Thyroid storm after coronary artery bypass grafting. J. Thorac. Cardiovasc Surg. 140(5), e67\u2013e69 (2010). https:\/\/doi.org\/10.1016\/j.jtcvs.2010.06.034","journal-title":"J. Thorac. Cardiovasc Surg."},{"issue":"4","key":"3679_CR36","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.hrtlng.2013.04.002","volume":"42","author":"S Alkhuja","year":"2013","unstructured":"S. Alkhuja, R. Pyram, O. Odeyemi, In the eye of the storm: iodinated contrast medium induced thyroid storm presenting as cardiopulmonary arrest. Heart Lung 42(4), 267\u2013269 (2013). https:\/\/doi.org\/10.1016\/j.hrtlng.2013.04.002","journal-title":"Heart Lung"},{"issue":"6","key":"3679_CR37","doi-asserted-by":"publisher","first-page":"e125","DOI":"10.1016\/j.jemermed.2017.08.096","volume":"53","author":"W Brundridge","year":"2017","unstructured":"W. Brundridge, J. Perkins, Iodinated contrast administration resulting in cardiogenic shock in patient with uncontrolled Graves disease. J. Emerg. Med 53(6), e125\u2013e128 (2017). https:\/\/doi.org\/10.1016\/j.jemermed.2017.08.096","journal-title":"J. Emerg. Med"},{"issue":"1","key":"3679_CR38","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1097\/CCM.0000000000004078","volume":"48","author":"S Bourcier","year":"2020","unstructured":"S. Bourcier, M. Coutrot, A. Kimmoun, R. Sonneville, E. de Montmollin, R. Persichini, D. Schnell, J. Charpentier, C. Aubron, E. Morawiec, N. Big\u00e9, S. Nseir, N. Terzi, K. Razazi, E. Azoulay, A. Ferr\u00e9, Y. Tandjaoui-Lambiotte, O. Ellrodt, S. Hraiech, C. Delmas, F. Barbier, A. Lautrette, N. Aissaoui, X. Repess\u00e9, C. Pichereau, Y. Zerbib, J.B. Lascarrou, S. Carreira, D. Reuter, A. Fr\u00e9rou, V. Peigne, P. Fillatre, B. Megarbane, G. Voiriot, A. Combes, M. Schmidt, Thyroid Storm in the ICU: A Retrospective Multicenter Study. Crit. Care Med 48(1), 83\u201390 (2020). https:\/\/doi.org\/10.1097\/CCM.0000000000004078","journal-title":"Crit. Care Med"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-023-03679-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-023-03679-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-023-03679-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,13]],"date-time":"2024-07-13T09:29:11Z","timestamp":1720862951000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-023-03679-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,9]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,7]]}},"alternative-id":["3679"],"URL":"https:\/\/doi.org\/10.1007\/s12020-023-03679-y","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,9]]},"assertion":[{"value":"17 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}